Holding(s) in Company

Dechra Pharmaceuticals PLC

21 November 2023

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
Merrill Lynch International	London	United Kingdom

5. Date on which the threshold was crossed or reached

17-Nov-2023

6. Date on which Issuer notified

20-Nov-2023

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	5.297374	1.237361	6.534735	7442511
Position of previous notification (if applicable)	4.792199	1.240060	6.032259

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		6033263		5.297374
Sub Total 8.A	6033263		5.297374%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Right to Recall	N/A	N/A	10928	0.009595
Sub Total 8.B1			10928	0.009595%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Swaps	06/12/2023	N/A	Cash	68650	0.060277
Swaps	15/02/2024	N/A	Cash	17738	0.015574
Swaps	17/04/2024	N/A	Cash	310418	0.272556
Swaps	29/04/2024	N/A	Cash	230275	0.202188
Swaps	21/05/2024	N/A	Cash	15604	0.013701
Swaps	03/06/2024	N/A	Cash	391	0.000343
Swaps	08/07/2024	N/A	Cash	107865	0.094709
Swaps	31/07/2024	N/A	Cash	345303	0.303186
Swaps	12/08/2024	N/A	Cash	246	0.000216
Swaps	27/08/2024	N/A	Cash	120	0.000105
Swaps	16/09/2024	N/A	Cash	2	0.000002
Swaps	30/09/2024	N/A	Cash	105	0.000092
Swaps	07/10/2024	N/A	Cash	2886	0.002534
Swaps	31/10/2024	N/A	Cash	2491	0.002187
Swaps	08/11/2024	N/A	Cash	20000	0.017561
Swaps	11/11/2024	N/A	Cash	2	0.000002
Swaps	18/11/2024	N/A	Cash	11551	0.010142
Swaps	09/12/2024	N/A	Cash	348	0.000306
Swaps	17/12/2024	N/A	Cash	261912	0.229966
Swaps	06/05/2025	N/A	Cash	2413	0.002119
Sub Total 8.B2				1398320	1.227766%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Bank of America Corporation	Bank of America, National Association
Bank of America Corporation	Merrill Lynch International	4.987993		5.314896%
Bank of America Corporation	BofA Securities Europe SA

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

20-Nov-2023

13. Place Of Completion

United Kingdom

 

END